diabetic-nephropathy

Documents about diabetic-nephropathy

• Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians#826120ClinicalTrials.gov
• The Relationship Between Nephrotoxic Serum Trace Elements and Renal Function Tests in Diabetic Nephropathy#188981Zenodo (CERN)
• Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease#300406ClinicalTrials.gov
• RAB27A silencing modulates miR-30d-5p expression and extracellular vesicle non-coding RNA cargo in diabetic podocytes#476185IRIS
• Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)#253166ClinicalTrials.gov
• Glucocorticoids combined with rituximab treatment for IgG4-related tubulointerstitial nephritis with diabetic nephropathy: a case report.#1039890NCBI PubMed Central
• Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus#968220ClinicalTrials.gov
• Time to diabetic nephropathy and its predictors among adult diabetic patients at public general and referral hospitals in South Wollo Zone, Northeast Ethiopia: A retrospective follow up study.#440889NCBI PubMed Central
• Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.#801574ClinicalTrials.gov
• Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia#862478ClinicalTrials.gov
• Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy#628665ClinicalTrials.gov
• Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure#127722ClinicalTrials.gov
• A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic Nephropathy#332668ClinicalTrials.gov
• Mechanistic Elucidation of Yiqi Yangyin Qingre Decoction in Diabetic Nephropathy Therapy via Network Pharmacology and In Vivo Validation.#446325NCBI PubMed Central
• Hyperglycemic stress aggravates diabetic retinopathy and nephropathy by promoting cilium disassembly via a deacetylation- and methylation-mediated regulatory mechanism.#653313NCBI PubMed Central
• Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects#898615ClinicalTrials.gov
• Association of the platelet-to-albumin ratio with diabetic nephropathy lesions via a fine-tuning-free large language model framework.#258212NCBI PubMed Central
• Morphological and Biochemical Insights Into the Renoprotective Effects of Combined N-Acetylcysteine and Glycine Treatment in Experimental Diabetic Nephropathy.#265481NCBI PubMed Central
• Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study#854804ClinicalTrials.gov
• Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.#858733ClinicalTrials.gov
• Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study#995592ClinicalTrials.gov
• Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor#982373ClinicalTrials.gov
• Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes#121256ClinicalTrials.gov
• Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes#127749ClinicalTrials.gov
• Metformin in Diabetic Patients Undergoing Coronary Angiography#279478ClinicalTrials.gov
• Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy#373742ClinicalTrials.gov
• Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes#899691ClinicalTrials.gov
• Clinical utility of BOLD-MRI in accurate diagnosis and prognostic evaluation of diabetic nephropathy: a prospective renal biopsy-based cohort study.#122782NCBI PubMed Central
• A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease#827281ClinicalTrials.gov
• Mesenchymal Stem Cells for Chronic Kidney Diseases#849396ClinicalTrials.gov
• A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril#162342ClinicalTrials.gov
• Omega-3 Fatty Acids Supplementation Improves Early-stage Diabetic Nephropathy and Subclinical Atherosclerosis in Pediatric Patients With Type 1 Diabetes#829130ClinicalTrials.gov
• COL1A2 and APOLD1 Define a Dual-Axis Molecular Framework for Diabetic Nephropathy-Retinopathy Comorbidity: An Integrative Multiomics and Machine Learning Study in Mouse Models.#653349NCBI PubMed Central
• Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes#830164ClinicalTrials.gov
• Extracellular Vesicle-Derived MicroRNAs as Early Diagnostic Biomarkers of Diabetic Nephropathy and Cardiovascular Diseases in Type 2 Diabetes#314726Europe PMC
• Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes#245464ClinicalTrials.gov
• Adiponectin in Obese Women With T2DN and Effects by RAS Blocker#831197ClinicalTrials.gov
• Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function#859005ClinicalTrials.gov
• Image 7_A novel LepR knockout hamster model for type 2 diabetes and its complications: a complementary platform to conventional rodent models.jpg#451873Figshare
• Table 1_A novel LepR knockout hamster model for type 2 diabetes and its complications: a complementary platform to conventional rodent models.docx#451874Figshare
• Image 2_A novel LepR knockout hamster model for type 2 diabetes and its complications: a complementary platform to conventional rodent models.tif#451876Figshare
• Image 1_A novel LepR knockout hamster model for type 2 diabetes and its complications: a complementary platform to conventional rodent models.tif#451877Figshare
• Image 5_A novel LepR knockout hamster model for type 2 diabetes and its complications: a complementary platform to conventional rodent models.tif#451878Figshare
• Image 4_A novel LepR knockout hamster model for type 2 diabetes and its complications: a complementary platform to conventional rodent models.tif#451879Figshare
• Image 3_A novel LepR knockout hamster model for type 2 diabetes and its complications: a complementary platform to conventional rodent models.tif#451880Figshare
• Supplementary file 1_A novel LepR knockout hamster model for type 2 diabetes and its complications: a complementary platform to conventional rodent models.docx#451875Figshare
• Comparison of Soy-milk and Cow Milk Consumption on Inflammatory Factors, Cardiovascular Factors ,Renal Factors, Fibrinolytic Indice and Oxidative Stress Among Type-2 Diabetic Patients With Nephropathy Stage 1 and 2#857733ClinicalTrials.gov